IIT Roorkee Secures Breakthrough in Chikungunya Research with Potential Drug Discovery

​ IIT Roorkee, India March 17th, 2025: Scientists at the Indian Institute of Technology (IIT) Roorkee have studied a new possibility for treating Chikungunya, a mosquito-borne viral disease that causes fever, joint pain, muscle pain, and rash. Their research indicates that Efavirenz, a drug widely used for HIV treatment, may also serve as an effective therapy IIT Roorkee, India March 17th, 2025: Scientists at the Indian Institute of Technology (IIT) Roorkee have studied a new possibility for treating Chikungunya, a mosquito-borne viral disease that causes fever, joint pain, muscle pain, and rash. Their research indicates that Efavirenz, a drug widely used for HIV treatment, may also serve as an effective therapy